LETTER
Direct Synthesis of Polybenzylated Glutamic Acid Monoesters
2169
was extracted with EtOAc (3 × 50 mL). The organic extracts were
combined, and the solvent was removed under reduced pressure.
The solid residue was recrystallized from MeOH to give 9 as a white
the process (10% yield). For processes where the α-ester
should be transformed and thus transesterification is not
an inconvenience, the yield adds up to 83%.
solid (5.8 g, 90% yield): mp 228–229 °C; [α]25 –71.3 (c 1.03,
D
DMSO). 1H NMR (400 MHz, DMSO-d6): δ = 1.84–1.90 (m, 2 H),
2.13–2.21 (m, 1 H), 2.29–2.36 (m, 1 H), 3.12–3.16 (m, 1 H), 3.59
(d, J = 14.2, 2 H), 3.80 (d, J = 14.2, 2 H), 7.20–7.32 (m, 10 H) ppm.
13C NMR (100 MHz, DMSO-d6): δ = 24.2, 30.6, 50.0, 59.86, 126.3,
128.2, 128,4, 139.6, 173.6, 174.05 ppm. IR: νmax = 3340.3–2750.4,
2672.3–2172.5, 1729.3, 1612.6, 1452.6, 1245.5 cm–1. ESI-HRMS:
m/z calcd for C19H20NO4 [M + 2Na]+ 372.1188; found: 372.1180.
In summary, we have described a methodology to obtain
both N,N-dibenzylglutamic acid monobenzyl esters 7 and
8 from commercially available L-glutamic acid (1). Both
1
compounds can be differentiated in terms of their H
NMR spectra. The unprecedented compound 7 is reported
and characterized for the first time. The preferred method
to obtain 7 from L-glutamic acid is the three-step process
reported herein. We explored the reaction conditions lead-
ing to the formation of 8. A not optimized 73% yield was
achieved plus 10% yield of the N,N-dibenzylglutamic acid
α-methyl ester.
Acknowledgment
Cofinanced by the EU Research Potential (FP7-REGPOT-2012-
CT2012-31637-IMBRAIN), the European Regional Development
Fund (FEDER), the Spanish Ministerio de Educación (Programa
Campus de Excelencia Internacional CEI10/00018), the Spanish
MINECO (CTQ2011-28417-C02-01 and Instituto de Salud Carlos
III PI11/00840). G.S.-D. thanks the EU Social Fund (FSE) and the
Canary Islands ACIISI for a predoctoral grant.
(2S)-5-(Benzyloxy)-2-(dibenzylamino)-5-oxopentanoic Acid (7)
Methane sulfonic acid (3.6 mmol, 0.2 mL) was added dropwise to a
suspension of 9 (1.0 g, 3 mmol) and benzyl alcohol (4.8 mmol, 0.5
mL) in dry toluene (30 mL). The resulting mixture was heated at re-
flux in a Dean–Stark system for 5 h, after which time it was allowed
to cool to r.t. Then, the solvent was evaporated under reduced pres-
sure. The residue was diluted with H2O (30 mL) and extracted with
Et2O (2 × 20 mL). The combined organic extracts were washed with
brine (30 mL) and dried over MgSO4, filtered, and the solvent was
removed under reduced pressure. The residue was purified by flash
Supporting Information for this article is available online
at
10.1055/s-00000083.SunogIpimrfiantoSuIpg
n
fonirtat
ori
References
column chromatography (hexanes–EtOAc, 20:50) to give 1.3 g of 7
1
(70% yield) as pale yellow oil. [α]25 –31.3 (c 0.98, CHCl3). H
(1) (a) Padrón, J. M. Curr. Med. Chem. 2006, 13, 755.
(b) Padrón, J. M.; Peters, G. J. Invest. New Drugs 2006, 24,
195. (c) Markidis, T.; Padrón, J. M.; Martín, V. S.; Peters, G.
J.; Kokotos, G. Anticancer Res. 2001, 21, 2835. (d) Padrón,
J. M.; Martín, V. S.; Hadjipavlou-Litina, D.; Noula, C.;
Constantinou-Kokotou, V.; Peters, G. J.; Kokotos, G.
Bioorg. Med. Chem. Lett. 1999, 9, 821.
(2) Kokotos, G.; Padrón, J. M.; Noula, C.; Gibbons, W. A.;
Martín, V. S. Tetrahedron: Asymmetry 1996, 7, 857.
(3) (a) Kokotos, G.; Padrón, J. M.; Martín, T.; Gibbons, W. A.;
Martín, V. S. J. Org. Chem. 1998, 63, 3741. (b) Padrón, J.
M.; Kokotos, G.; Martín, T.; Markidis, T.; Gibbons, W. A.;
Martín, V. S. Tetrahedron: Asymmetry 1998, 9, 3381.
(4) (a) Sutherland, A.; Caplan, J. F.; Vederas, J. C. Chem.
Commun. 1999, 555. (b) Sutherland, A.; Vederas, J. C.
Chem. Commun. 1999, 1739. (c) Roche, D.; Prasad, K.;
Repic, O.; Blacklock, T. J. Tetrahedron Lett. 2001, 42, 1459.
(d) Adamczyk, M.; Reddy, R. E.; Rege, S. D. J. Labelled
Compd. Radiopharm. 2001, 44, 185. (e) Hernández, N.;
Martín, V. S. J. Org. Chem. 2001, 66, 4934.
D
NMR (500 MHz, CDCl3): δ = 2.11–2.21 (m, 2 H), 2.53–2.66 (m, 2
H), 3.47 (t, J = 7.0 Hz, 1 H), 3.78 (d, J = 13.4 Hz, 2 H), 3.91 (d, J =
13.4 Hz, 2 H), 5.08 (AB system, 2 H) 7.29–7.42 (m, 15 H) ppm. 13
C
NMR (100 MHz, CDCl3): δ = 22.9, 31.1, 54.5, 60.2, 66.3, 127.6,
128.3, 128.6, 129.2, 135.9, 138.2, 172.9, 176.5 ppm. IR: νmax
=
3362.1–2328.4, 1729.2, 1257.4, 1162.4 cm–1. ESI-HRMS: m/z cal-
cd for C26H27NO4 [M + H]+: 418.2018; found: 418.2002.
(4S)-5-(Benzyloxy)-4-(dibenzylamino)-5-oxopentanoic Acid (8)
To a solution of L-glutamic acid (1.0 g, 6.8 mmol), K2CO3 (2.2 g,
15.6 mmol), and KOH (0.87 g, 15.6 mmol) in MeOH–H2O (1:1, 30
mL) was slowly added benzyl bromide (4.08 g, 23.8 mmol) at r.t.
The mixture was stirred at 70 °C for 5 h. After being cooled to 0 °C,
it was neutralized (pH 7) with a 5% solution of HCl. Then, the mix-
ture was extracted with CH2Cl2 (2 × 50 mL), and the organic layer
was dried over MgSO4, filtered, and the solvent was removed under
reduced pressure. The residue was purified by flash column chro-
matography (hexanes–EtOAc, 90:10 to 70:30) to give 700 mg of 8
(25% yield) as a colorless oil. [α]25D –72.7 (c 1.11, CHCl3). 1H NMR
(400 MHz, CDCl3): δ = 2.00–2.14 (m, 2 H), 2.33–2.40 (m, 1 H),
2.46–2.54 (m, 1 H), 3.45 (dd, J = 6.7, 9.5 Hz, 1 H), 3.54 (d, J = 14.3
Hz, 2 H), 3.94 (d, J = 14.3 Hz, 2 H), 5.26 (AB system, 2 H), 7.22–
7.48 (m, 15 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 23.9, 30.4,
54.5, 59.6, 66.2, 127.2, 128.3, 128.4, 128.6, 128.6, 128.4, 135.9,
138.9, 172.0, 178.79 ppm. IR: νmax = 3450.3–2500.2, 1729.7,
1711.1, 1247.8, 1160.7 cm–1. ESI-HRMS: m/z calcd for C26H27NO4
[M + Na]+: 440.1838; found: 440.1846.
(f) Constantinou-Kokotou, V.; Magrioti, V.; Markidis, T.;
Kokotos, G. J. Peptide Res. 2001, 58, 325. (g) Magrioti, V.;
Constantinou-Kokotou, V. Lipids 2002, 37, 223.
(h) Wasserman, H. H.; Long, Y. O.; Zhang, R.; Parr, J.
Heterocycles 2002, 58, 393. (i) Constantinou-Kokotou, V.
Lett. Peptide Sci. 2002, 9, 143. (j) Wasserman, H. H.; Long,
Y. O.; Zhang, R.; Parr, J. Tetrahedron Lett. 2002, 43, 3351.
(k) Hanessian, S.; Angiolini, M. Chem. Eur. J. 2002, 8, 111.
(l) Schleusner, M.; Gais, H.-J.; Koep, S.; Raabe, G. J. Am.
Chem. Soc. 2002, 124, 7789. (m) Cox, R. J.; Gibson, J. S.;
Martín, M. B. M. ChemBioChem 2002, 3, 874. (n) Gerwick,
W. H.; Leslie, P.; Long, G. C.; Marquez, B. L.; Willis, C. L.
Tetrahedron Lett. 2003, 44, 285. (o) Bycroft, B. W.;
Chhabra, S. R.; Kellam, B.; Smith, P. Tetrahedron Lett.
2003, 44, 973. (p) Abraham, A.; Howarth, N. M.
(2S)-2-(Dibenzylamino)pentanedioic Acid (9)
Perbenzylated L-glutamic acid (2, 10 g, 19.7 mmol) was dissolved
in MeOH (70 mL). A freshly prepared, ice-cold aq solution of 2.4
M NaOH (22 mL, 50 mmol) was added to the solution, and the re-
sulting mixture was heated at reflux for 20 h. The reaction mixture
was then allowed to cool to r.t., and the solvent was evaporated un-
der reduced pressure. The residue was diluted with H2O and extract-
ed with CH2Cl2 to remove the benzyl alcohol formed in the
hydrolysis. The basic aqueous layer was acidified (pH 3–4) with
concentrated HCl, and a precipitate was formed. The water layer
Nucleosides, Nucleotides Nucleic Acids 2003, 22, 675.
(q) Gorohovsky, S.; Meir, S.; Shkoulev, V.; Byk, G.;
Gellerman, G. Synlett 2003, 1411. (r) Hallinan, E. A.;
© Georg Thieme Verlag Stuttgart · New York
Synlett 2014, 25, 2166–2170